Döşkaya Mert

Assoc. Dr. Mert Döşkaya is the vice director of Ege University Medical Faculty, Department of Parasitology, Molecular Parasitology Diagnostic Laboratory and Vaccine Research and Development Laboratory. He is a professor in the field of DNA and Recombinant protein vaccine development. He studied vaccinology at the University of California, Irvine with TUBITAK doctoral scholarship. He also studied ERASMUS Scholarship and Molecular Diagnosis and Genotyping at Limoges University, France. He worked as a volunteer doctor in Kocaeli earthquake in 1999. His researches on vaccine and molecular diagnostic test development with his colleagues have been awarded by various scientific associations, EBILTEM and TUBITAK. He also worked as a volunteer medical doctor in Kocaeli earthquake in 1999. His research about vaccine development and molecular diagnostic testing with his colleagues has been awarded by various scientific associations such as EBILTEM, TUBITAK and International Society of Vaccines (ISV). He has co-authored 31 publications in the journals scanned by SCI, 10 publications in the non-SCI journals, 43 international oral or poster publications, 112 national presentations, and 8 book chapters. In addition, He worked as a referee in 20 different journals screened by the SCI, as well as a referee and a national magazine editor. His current H-index is 13. In addition, He has been a reviewer and rapporteur for the European Commission, Eurostars, ANF (Agence Nationale de la Recherche, France), IFD (Innovation Fund Denmark) , SEAEUROPE, TÜBİTAK projects since 2012. He has worked as a researcher or principal investigator in 25 national projects. His current research interests include the development of recombinant protein-based ELISA and multiplex real-time PCR diagnostic techniques, microsatellite genotyping, and detection of antigenic vaccine candidates or diagnostic proteins by screening with protein microarrays, and the development of DNA and recombinant protein vaccines for the treatment of infectious agents and cancer. In 2014, he and his colleagues established the first “Vaccinology Society of Turkey” (http://www.asibilimidernegi.org/). In 2015, he and his colleagues established EgeDiaVac Research and Innovation Company by National R&D Innovation Support. In 2009, he has started to establish the first Vaccine R&D Institute of Turkey in Ege University.